Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Sami EVİRGEN"'
Autor:
Raim Iliaz, Sinem Iliaz, Sami Evirgen, Bilger Cavus, Filiz Akyuz, Kadir Demir, Sabahattin Kaymakoglu, Fatih Salman Besisik
Publikováno v:
Journal of Enterocolitis. 4:33-36
Autor:
Sami EVİRGEN, Alaattin YILDIZ
Publikováno v:
Batı Karadeniz Tıp Dergisi. 5:380-385
Aim: Hypervolemia is a common problem in hemodialysis (HD) patients. Because reaching to optimal dry weight (DW) is difficult. Chronic volume overload causes left ventricular hypertrophy. Therefore, risk of cardiovascular events is very high. High pu
Autor:
Sami, Evirgen, Raim, İliaz, Filiz, Akyüz, Bilger, Çavuş, Suut, Göktürk, Aslı, Örmeci, Özlem, Mutluay Soyer, Bülent, Baran, Binnur, Pınarbaşı, Çetin, Karaca, Kadir, Demir, Fatih, Beşışık, Sabahattin, Kaymakoğlu
Publikováno v:
Turk J Gastroenterol
BACKGROUND: Cyclosporine is a rescue treatment alternative to avoid colectomy in corticosteroid refractory acute severe ulcerative colitis. In this study, we aimed to evaluate the long-term efficacy and safety of cyclosporine therapy in acute sever
Autor:
Sami EVİRGEN
Publikováno v:
Volume: 21, Issue: 2 59-62
Akademik Gastroenteroloji Dergisi
The Turkish Journal of Academic Gastroenterology
Akademik Gastroenteroloji Dergisi
The Turkish Journal of Academic Gastroenterology
Background and Aims: Duodenal scattered white spot lesions, which we usually encounter and evaluate as intestinal lymphangiectasia in routine endoscopic evaluation, are mostly unknown for a cause or clinical equivalent. In our study, we aimed to eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26d28b51233dd9c55776cda3f03fff3a
https://dergipark.org.tr/tr/pub/agd/issue/72292/1154091
https://dergipark.org.tr/tr/pub/agd/issue/72292/1154091
Autor:
Filiz Akyüz, Bilger Çavuş, Nihan Nizam, Suut Göktürk, Bülent Baran, Halil Yazıcı, Sami Evirgen, Ümit Akyüz, Tuba Öbekli, Çetin Karaca, Kadir Demir, Fatih Beşışık, Sabahattin Kaymakoğlu
Publikováno v:
Clinical and experimental hepatology. 8(1)
There are limited data about the safety of tenofovir disoproxil fumarate (TDF) in chronic renal failure (CRF). In this study, we aimed to evaluate the safety and efficacy of TDF in renal transplant recipients and hemodialysis patients with chronic he
Autor:
Sami Evirgen, Selda Karaveli Cakir
Publikováno v:
Turk J Gastroenterol
BACKGROUND: The aim of the study is to evaluate the effect of virtual reality application during a colonoscopy on the pain and anxiety experienced by patients. METHODS: The study was conducted as experimental, randomized, controlled research. The stu
Autor:
Kaya Koksalan, Ozlem Mutluay Soyer, Raim Iliaz, Metin Keskin, Mine Gulluoglu, Asli Ormeci, Bilger Cavus, Cetin Karaca, Sabahattin Kaymakoglu, Kadir Demir, Filiz Akyuz, Semen Onder, Tulin Cagatay, Fatih Besisik, Sami Evirgen
Publikováno v:
European Journal of Gastroenterology & Hepatology. 31:777-780
OBJECTIVES Isoniazid (INH) prophylaxis is recommended for the prevention of tuberculosis (TB) reactivation before or/and during initiation of treatment with tumour necrosis factor antagonists (anti-TNF agents). Nonetheless, the long-term effectivenes
Autor:
C. Karaca, Sami Evirgen, Murat Serilmez, Filiz Akyuz, Raim Iliaz, Kadir Demir, Bilger Cavus, Derya Duranyildiz, Umit Akyuz, D. Tekin, Sabahattin Kaymakoglu, Fatih Besisik
Publikováno v:
Experimental Oncology. 42
Hepatocellular carcinoma (HCC) is an increasing problem worldwide. Determining a prognosis is important for the management of HCC.We aimed to investigate the impact of interleukin (IL)-29, galectin-3, leptin, fibronectin and protease-activated recept
Autor:
ertaç berker, Kevser Onbasi, Dilek Beypinar, Bengur Taskiran, Ekici Mehmet Fatih, Sami Evirgen
Publikováno v:
Endocrine Abstracts.
Autor:
Selcen Yuksel, Esra Erden, Ramazan Idilman, Gökhan Kabaçam, Hakan Bozkaya, Cihan Yurdaydin, Kubra Akan, Filiz Akyüz, Kubilay Cinar, Sami Evirgen, Sabahattin Kaymakoglu, Handan Yarkan Tugsal, Mine Gulluoglu, A. Mithat Bozdayi
Publikováno v:
Hepatology Forum.
This study was designed to predict the fibrosis stage with a clinical scoring system that may reduce the need for liver biopsy.The study cohort included the treatment of 430 chronic hepatitis B (CHB) and 170 chronic hepatitis C (CHC) of naive patient